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Abstract
While numerous studies have described the pathogenic and carcinogenic effects of nickel compounds, little has been done
on the biological effects of metallic nickel. Moreover, the carcinogenetic potential of metallic nickel nanoparticles is
unknown. Activator protein-1 (AP-1) and nuclear factor-kB (NF-kB) have been shown to play pivotal roles in tumor initiation,
promotion, and progression. Mutation of the p53 tumor suppressor gene is considered to be one of the steps leading to the
neoplastic state. The present study examines effects of metallic nickel fine and nanoparticles on tumor promoter or
suppressor gene expressions as well as on cell transformation in JB6 cells. Our results demonstrate that metallic nickel
nanoparticles caused higher activation of AP-1 and NF-kB, and a greater decrease of p53 transcription activity than fine
particles. Western blot indicates that metallic nickel nanoparticles induced a higher level of protein expressions for R-Ras, c-
myc, C-Jun, p65, and p50 in a time-dependent manner. In addition, both metallic nickel nano- and fine particles increased
anchorage-independent colony formation in JB6 P+ cells in the soft agar assay. These results imply that metallic nickel fine
and nanoparticles are both carcinogenetic in vitro in JB6 cells. Moreover, metallic nickel nanoparticles may exhibit higher
carcinogenic potential, which suggests that precautionary measures should be taken in the use of nickel nanoparticles or its
compounds in nanomedicine.
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Introduction
In recent years, nanotechnology has brought a lot of improve-
ments and advances in the treatment and diagnosis of diseases due
to the development of improved contrast agents [1,2], and drug
delivery vehicles [3,4,5] using nanomaterials. The use of metallic
nanoparticles and their compounds have been paramount in such
advances. Nickel (Ni) and Ni compound nanoparticles are also
among those being investigated, for example nickel zinc (NiZn)
ferrite [6]. While many studies have been published on the
carcinogenicity of nickel compounds [7,8,9], the carcinogenicity of
metallic nickel is still uncertain [10,11,12]. In vivo experiments
and epidemiology studies show that nickel compounds are
carcinogenic [13]. Therefore, nickel compounds are classified by
the International Agency for Research on Cancer (IARC) as
carcinogens to human being [14]. Though the epidemiological
studies on the carcinogenicity metallic nickel are not conclusive
[15], experimental animal studies suggest that metallic nickel
nanoparticles may be carcinogenic [10]. Nickel nanoparticles are
widely used in industry due to its unique characteristics with
production estimated to be around 20 tons per year in the United
States [16]. However, concern has been expressed that these same
properties of nickel nanoparticles may also present unique
bioactivity and challenges to human health [17].
We have previously shown that metallic nickel nanoparticles
induced higher up-regulation of phospho-Akt (protein kinase B)
and Bcl-2 than fine particles [18]. Zhang et al found that metallic
nickel nanoparticles had a much more toxic effect on the lung than
metallic nickel fine particles, but the mechanism remains to be
elucidated [19]. Roy et al reported that Akt proto-oncogene
overexpression is an early event during sporadic colon carcino-
genesis [20]. Therefore, up-regulation of proto-oncogenes may be
important in the carcinogenicity of metallic nickel particles. Based
on the fact that nanoparticles of metallic nickel and TiO2 cause
more pronounced toxicity compared with their fine particles
[18,21,22,23,24], particle size may be also an important factor for
the carcinogenicity of metallic nickel particles [25]. Accordingly,
an in vitro comparative study was performed on the carcinogenicity
of metallic nickel nano- and fine particles.
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Materials and Methods
Materials
Metallic nickel nanoparticles (average size 80 nm), fine particles
(average size of 3 mm, Eagle’s minimal essential medium (EMEM),
Opti-MEM I medium, fetal bovine serum (FBS), trypsin,
penicillin/streptomycin and L-glutamine, Alexa Fluor 488 donkey
anti-goat antibody, antibodies, and luciferase assay substrate were
purchased from the same companies as used in our previous study
[18]. Protease inhibitor cocktail and 12-O-tetradecanoylphorbol-
13-acetate (TPA) was purchased from Sigma Chemical Co. (St.
Louis, MO).
Methods
1. Preparation of metallic nickel nano- and fine
particles. Metallic nickel nano- and fine particles were
prepared as in our previous study [18]. Briefly, under sterile
conditions, stock solutions of metallic nickel nano- or fine particles
were prepared by sonification on ice (Branson Ultrasonics Corp.,
Danbury, CT) in sterile PBS (10 mg/ml) for a total of 3 min at a
power of 400 W with interval changes of 30 sec sonication and
15 sec on ice. Before use, these particles were diluted to a designed
concentration in fresh culture medium.
2. Size distribution and surface area
measurements. The size distribution and surface area of
metallic nickel particles were detected following the procedures
used in our previous study [18]. Briefly, Surface area of metallic
nickel particles was measured using the Gemini 2360 Surface Area
Analyzer (Mircomeritics; Norcross, GA) with a flowing gas
technique according to the manufacturer’s instructions. The size
distribution of metallic nickel particles was detected using scanning
electron microscopy (SEM; Hitachi S-4800; Japan) according to
Figure 1. Induction of c-Jun nuclear translocation and AP-1 activation by metallic nickel particles. JB6 cells, stably transfected with AP-1
luciferase reporter plasmid, were seeded onto 24-well plate and incubated overnight. Cells were treated with/without metallic nickel nano- or fine
particles for 24 h. (A) Effect of metallic nickel particles on nuclear translocation of the c-Jun subunit of AP-1 as measured by indirect
immunofluorescence analysis using an anti-c-Jun primary antibody. The bright greenish areas represent nuclei that stained with anti-c-Jun antibody.
After treatments, cells were fixed, permeabilized, blocked, and stained with monoclonal c-Jun antibody for 3 h. Alexa Fluor 488 goat anti-rabbit
secondary antibody was added for 1 h. AP-1 is 100% expression in all cell nuclei, metallic nickel nano- or fine particles may increase the expression
(staining density) in the cell nucleus. (B) The AP-1 activity was measured by the luciferase activity assay. Results are means and standard errors of four
assay wells. The experiment was repeated two times. * P,0.05 versus control; { P,0.05 versus fine particles. TPA (20 ng/ml) was set as a positive
control.
doi:10.1371/journal.pone.0092418.g001
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the manufacturer’s instructions. Optimas 6.5 image analysis
software (Media Cybernetics; Bethesda, MD) was used to measure
the diameter of metallic nickel particles.
3. Cell culture. Mouse epidermal JB6 cells were obtained
from Dr. Colburn’ Lab (see reference No. 35) and cultured in 5%
FBS EMEM supplemented with 2 mM L-glutamine and penicil-
lin-streptomycin (10,000 U/ml penicillin and 10 mg/ml strepto-
mycin) at 37uC (80% humidified air, and 5% CO2).
4. Immunocytochemistry staining. JB6 cells were cultured
in a 24-well plate until 60 to 80% confluent. Then, the cells were
treated with metallic nickel fine or nanoparticles in 5% FBS
EMEM for 24 h. Cells were fixed with 4% para-formaldehyde in
PBS, permeabilized with 0.5% Triton X-100/PBS for 30 min, and
blocked with 3% bovine serum albumin in PBS for 1 h at 37uC.
The cells were then incubated with C-Jun or p65 antibody at 4uC
overnight. After washing with PBS, Alexa Fluor 488 secondary
antibody was added. Cells were incubated at room temperature
for 2 h. The cells were then washed twice with PBS, and
resuspended in fresh PBS (0.2 ml/well). Fluorescence images were
acquired with an immunofluorescence microscope.
5. Western blot analysis. Briefly, cells were plated onto a 6-
well plate. The cultures were grown 24 h and then starved in 0.1%
FBS EMEM overnight. Cells were treated with metallic nickel
nano- or fine particles for 1, 3, 6 or 8 h, respectively. After
treatment, western blot was conducted as stated in our previous
Figure 2. Induction of p65 nuclear translocation and NF-kB activation by metallic nickel particles. JB6 cells, stably transfected with NF-
kB luciferase reporter plasmid, were seeded onto 24-well plate and incubated overnight. Cells were treated with/without metallic nickel nano- or fine
particles for 24 h. (A) Effect of nickel particles on nuclear translocation of the p65 subunit of NF-kB as measured by indirect immunofluorescence
analysis using an anti-p65 primary antibody. The bright greenish areas represent nuclei that stained with anti-p65 antibody. After treatments, cells
were fixed, permeabilized, blocked, and stained with NF-kB monoclonal p65 antibody for 3 h. Alexa Fluor 488 goat anti-rabbit secondary antibody
was added for 1 h. NF-kB is 100% expression in all cell cytoplasm, metallic nickel nano- or fine particles may induce NF-kB translocation from
cytoplasm into the cell nucleus. (B) The NF-kB activity was measured by the luciferase activity assay. Results are mean and standard error of four assay
wells. The experiment was repeated two times. * P,0.05 versus control; { P,0.05 versus fine particles. TPA (20 ng/ml) was set as a positive control.
doi:10.1371/journal.pone.0092418.g002
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study [18]. Immunoblots for expressions of R-Ras, c-myc, C-Jun,
p65, p50, p53, HIF-1alpha and beta tubulin were detected.
Experiments were performed three or more times. Equal loading
of protein was conducted by measuring beta tubulin expression.
6. Detection of AP-1, NF-kB or p53 transcription
activity. JB6 cells, stably transfected with the AP-1, NF-kB or
p53-luciferase plasmid as described previously [26] were seeded
onto a 24-well plate. Cells (56104 in 1 ml of culture medium) were
grown 12 h and then starved in 0.1% FBS EMEM overnight.
Then, cells were exposed to different concentrations of metallic
nickel fine or nanoparticles (0–20 mg/cm2) for 24 h. Thereafter,
cells were lysed with 100 ml of luciferase lysis buffer. The luciferase
activity of AP-1, NF-kB or p53 was measured by addition of
luciferase assay substrate using a luminometer (Monolight 3010,
Analytical Luminescence Laboratory, San Diego, CA). The results
were expressed as relative AP-1, NF-kB or p53 luciferase activity
compared with untreated controls.
7. Anchorage-independent transformation assay. The
effect of metallic nickel fine or nanoparticles on cell anchorage-
independent transformation was evaluated in a JB6 P+ cell line
using the soft agar assay as described previously [27]. JB6 P+ cells
were treated with/without metallic nickel nano- or fine particles
(1 mg/cm2) until only a few live cells remained (approximately
three weeks). Live cells were then allowed to grow until confluent
in a 6-well plate, then the treatment, as stated above, was repeated
for a total of 3 times. Cells were then collected and stored in liquid
nitrogen until ready to use. Metallic nickel nano- or fine particle-
treated or non-treated JB6 P+ cells (16104) were incubated on soft
agar medium. The cultures were maintained in a humidified,
37uC, 5% CO2 incubator for 21 days. The anchorage-indepen-
dent colonies were counted as described previously [28,29]. 12-O-
tetradecanoylphorbol-13-acetate (TPA, 20 ng/ml) was set as a
positive control.
8. Statistical analysis. Significant differences were deter-
mined using R software or the Student’s t-test.
Results
1. Size distribution and surface area of metallic nickel
particles
To measure the size distribution and surface area of nickel
particles, scanning electron microscopy and Gemini 2360 Surface
Area Analyzer were used, respectively. The size distribution of
metallic nickel fine and nanoparticles is 3.3 mm and 92.3 nm,
Figure 3. Effects of metallic nickel particles on p53 transcription activity and protein levels. JB6 cells, stably transfected with p53
luciferase reporter plasmid, were seeded onto a 24-well plate and incubated overnight. Cells were treated with/without metallic nickel nano- or fine
particles for 24 h. The p53 transcription activity and protein levels were measured by the luciferase activity assay (A) and western-blot (B),
respectively. Metallic nickel nanoparticles caused a greater decrease of p53 transcription activity and protein levels than fine particles. * P,0.05 versus
control. TPA (20 ng/ml) or UVB (4 kJ/m2) were set as a positive control.
doi:10.1371/journal.pone.0092418.g003
Figure 4. Effects of metallic nickel particles on protein
expressions of R-Ras, c-myc, c-Jun, p65, p50 and HIF-1alpha.
JB6 cells were treated with 20 mg/cm2 metallic nickel nano- or fine
particles for 1, 3, 6 and 8 h. Western blot results show that both metallic
nickel nano- and fine particles induced up-regulation of protein
expressions of R-Ras, c-myc, c-Jun, p65, and p50 in a time-dependent
manner. Metallic nickel nanoparticles elicited a higher stimulation on
these protein expressions compared to fine particles. Nanoparticles
induced a significant HIF-1alpha up-regulation after 6 and 8 h
treatment.
doi:10.1371/journal.pone.0092418.g004
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respectively. The average surface area of metallic nickel fine and
nanoparticles are 0.4 m2/g and 4.0 m2/g, respectively.
2. Nuclear translocation of c-Jun and alteration of AP-1
activity after metallic nickel particle exposure
To determine the change of nuclear translocation of c-Jun and
the alteration of transcriptional activity of AP-1 following exposure
of metallic nickel particles, immunocytochemistry staining and
luciferase activity assay were performed. Immunocytochemistry
staining (Figure 1A) shows that c-Jun was significantly translocated
into the nuclei in cells after 24 h treatment with metallic nickel
nano- or fine particles compared to control. Luciferase activity
assay shows that both metallic nickel fine and nanoparticles
induced AP-1 transactivation with a dose-dependent manner. The
nanoparticles showed a significant higher AP-1 activation than fine
particles (Figure 1B).
3. Nuclear translocation of p65 and alteration of NF-kB
activity after metallic nickel particle exposure
To determine the changes in nuclear translocation of p65 and
alteration of transcriptional activity of NF-kB following exposure
of metallic nickel particles, immunochemistry staining and
luciferase activity assay were performed. Immunocytochemistry
staining (Figure 2A) shows that p65 was significantly transloctaed
into the nuclei in cells after 24 h treatment with metallic nickel
nano- or fine particles compared to control. Luciferase activity
assay show that both metallic nickel fine and nanoparticles
induced NF-kB transactivation with a dose-dependent manner.
NF-kB transcription activity induced by nanoparticles was
significantly higher than that induced by fine particles (Figure 2B).
4. Effects of metallic nickel particles on p53 activity and
protein levels
To study the effect of metallic nickel particles on p53
transcriptional activity, a JB6 cell line carrying a stably transfected
p53-luciferase reporter plasmid was used. The cells were exposed
to various doses of metallic nickel nano- or fine particles (1–20 mg/
cm2) for 24 h, and then the luciferase activity was determined. The
results show that both metallic nickel nano- and fine particles
significantly decreased p53 transcription activity in a dose-
dependent manner (Figure 3A). The maximum decrease of p53
transcription activity occurred at the concentration of metallic
nickel particles between 5 and 20 mg/cm2. p53 protein levels were
detected by western-blot (Figure 3B).
5. Effects of metallic nickel particles on R-Ras, c-myc, c-
Jun, p65, p50, and HIF-1a expression
To investigate the effects of metallic nickel particles on protein
expressions of R-Ras, c-myc, c-Jun, p65, p50, and HIF-1a,
western blot was performed. Metallic nickel fine or nanoparticles
induced up-regulation of protein expressions of R-Ras, c-myc, c-
Jun, p65, and p50 in a time-dependent manner. In addition, levels
of these protein expressions induced by nanoparticles were
significantly higher than that induced by fine particles. Nanopar-
ticles induced a significant HIF-1a up-regulation after 6 and 8 h
treatment (Figure 4).
6. Effects of metallic nickel particles on anchorage-
independent colony formation
Based on activation of metallic nickel particles on tumor
promoter AP-1 and NF-kB, our next aim was to determine
whether metallic nickel particles induce JB6 P+ cell transformation.
Cells (16104) pretreated with metallic nickel nano- or fine particles
as stated in the materials and methods were evaluated in a soft
agar assay for 21 days. The colonies formed in the soft agar were
recorded. The results indicate that both metallic nickel nano- and
fine particles induced JB6 P+ cell transformation. However, no
significant difference in colony transformation rates was found
between nano- and fine particle-treated cells (Figure 5).
Discussion
Nickel is a widely distributed metal. The high consumption of
various nickel products inevitably leads to occupational and
environmental pollution [30]. In occupational settings, about 10%
of all the primary nickel produced is used in metallic form [10].
Human exposure to nickel or its compounds has the potential to
produce a variety of pathological effects. The major health effect
of nickel exposure are skin allergies, lung fibrosis, and lung cancer
[14]. Numerous studies have documented the carcinogenicity of
nickel compounds [7,8,9], but the carcinogenic effect of metallic
nickel remains to be clarified. This paper provides evidence that
metallic nickel is carcinogenic with nanoparticles being more
carcinogenic than fine particles.
Toxicity of particles is not only related to exposure intensity but
also to the particle size [18]. Accordingly, more and more concern
has been raised on the health effects of metallic nickel
nanoparticles with their increase use in modern industries [31].
Our previous study shows that metallic nickel nanoparticles
were more toxic than fine particles. Metallic nickel nanoparticles
induced higher activation of phospho-Akt and Bcl-2 than fine
particles [18]. The physicochemical properties of metallic nickel
nanoparticles differ from their bulk material of the same
composition. However, little is known about the underlying effects
of metallic nickel nanoparticles in carcinogenesis. In the present
study, the potential carcinogenesis of metallic nickel fine and
nanoparticles was compared in a JB6 cell line in vitro. The JB6 cell
line is derived from primary cultures of neonatal BALB/c
epidermal cells and is suitable for studying differential responses
to tumor promoters.
Several cellular signaling transcription factors including AP-1
and NF-kB have been shown to play pivotal roles in tumor
initiation, promotion, and progression [32]. Activated AP-1 and
NF-kB are found in many different cancer cells [33] and may
result in the expression of target genes that are involved in
neoplastic transformation and tumor progression [34]. On the
contrary, inhibition of AP-1 and NF-kB activation has been shown
to reduce neoplastic transformation [35]. Studies in transgenic
mice indicate that AP-1 transactivation is required for tumor
promotion [35]. In addition, the signal transduction pathways of
AP-1 and/or NF-kB are known to be important molecular targets
of chemo-preventive strategies [36]. Our present results show that
both metallic nickel nano- and fine particles induced a dose-
related increase of AP-1 and NF-kB transcription activity in JB6
cells after 24 h exposure. Furthermore, metallic nickel nanopar-
ticles elicited stronger stimulation on transactivation of AP-1 or
NF-kB than fine particles. Immunocytochemistry staining indi-
cates that both c-Jun (subunit of AP-1) and p65 (subunit of NF-kB)
were significantly translocated into the nuclei in cells after 24 h
treatment with metallic nickel fine or nanoparticles. Luciferase
activity assay shows that both metallic nickel nano- and fine
particles significantly induced AP-1 and NF-kB activation with a
dose-dependent manner. Moreover, AP-1 or NF-kB activity
induced by nanoparticles was significantly higher than fine
particles within a certain dose range (see Figure 1B and
Figure 2B). This is in agreement with our previous study, which
indicated that metallic nickel nanoparticles elicited higher
Nickel Nanoparticles Exhibit Higher Carcinogenic
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activation of tumor promotion factors phospho-Akt and Bcl-2 than
fine particles [18]. Based on these results, metallic nickel
nanoparticles may be higher carcinogenic than fine particles. It
should be noted that surface area of metallic nickel nanoparticles is
10 times greater than fine particles, but increase of AP-1 or NF-kB
transcription activity induced by metallic nickel nanoparticles was
somewhat less than 11-fold greater than that induced by fine
particles. Therefore, bioactivity of metallic nickel particles may not
be proportional to their surface area. The human tumor
suppressor protein p53 is a key regulator of the response to
cellular stresses such as DNA damage, nucleotide depletion,
mitogenic oncogenes, and the tumor micro-environmental stress of
hypoxia [37,38]. The importance of p53 protein may be due to its
effect on cell cycle progression, including cell proliferation and
apoptosis [39,40]. A study by Wong et al showed that Ni (II) is a
strong activator of p53 protein in H460 human lung epithelial cells
[41]. They also stated that Ni(II)- activated p53 triggers caspase 9/
3-mediated apoptotic program and that it is an independent stress
response to hypoxia- mimicking Ni (II). However our results show
that p53 activation was decreased in JB6 cells treated with Ni
nanoparticles. This shows that in JB6 cells treated with Ni
nanoparticles, p53 activation maybe be suppressed due to
increased growth factor binding and stress response genes such
as HIF-1a. Cosse et al found that a decrease in p53 protein level
and an increase in c-Jun DNA binding activity induced by hypoxia
results in cancer cell resistance to anti-cancer drugs [42]. In
addition, Vormer et al reported that partial ablation of the p53
pathway strongly stimulated anchorage-independent growth of
Figure 5. Effects of metallic nickel particles on colony formation of JB6 P+ cells in soft agar assay. Metallic nickel nano- or fine particle-
treated or untreated JB6 P+ cells (16104) were incubated on soft agar medium for 21 days. TPA (20 ng/ml) was set as a positive control. (A) Images of
colony formation of JB6 P+ cells in soft agar assay. (a) Control. (b) TPA (20 ng/ml). (c) Metallic nickel fine particles. (d) Metallic nickel nanoparticles. (B)
Number of colonies/104 cells in soft agar assay. The cell colonies were scored by a computerized image analyzer. * P,0.05 versus untreated control.
doi:10.1371/journal.pone.0092418.g005
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mouse embryonic fibroblasts [43], while the mutation of the p53
tumor suppressor gene is considered to be one of the steps leading
to the neoplastic state [40].
Ras and c-myc are tumor promoter genes. Ras gene products
are involved in regulating cell growth and differentiation. Over
expression and amplification of the Ras gene can lead to
continuous cell proliferation, which is a major step in the
development of cancer [44]. Dysregulated expression of c-myc
oncogene is also associated with many malignancies [45]. Hypoxia
can modulate the activity of many transcription factors, such as
NF-kB, p53, c-myc, c-Jun, ETS-1, Egr-1, or SP-1 [46,47]. In the
present study, metallic nickel particles instigated a similar
bioactivity as hypoxia in JB6 cells, which include a decrease of
p53 and an increase of AP-1 and NF-kB trans- activation. Western
blots show that both metallic nickel nano- and fine particles
induced an increase of protein expressions of R-Ras, c-myc, c-Jun,
p65, and p50 in a time-dependent manner. Nanoparticles induced
a higher level of the expression of these proteins than fine particles.
HIF-1 is composed of HIF-1a and HIF-1b. The production of
HIF-1a has been identified as a key element in allowing cells to
adapt and survive in a hostile hypoxic environment via a variety of
pathways [48]. In the present study, only nanoparticles but not
fine particles induced significant HIF-1a up-regulation after 6 and
8 h treatment. These results suggest that further studies are needed
for clarifying the roles of hypoxia-inducible signaling pathway in
metallic nickel particle-induced carcinogenic process.
Anchorage independent growth is one of the hallmarks of
transformation and is considered to be the most accurate and
stringent in vitro assay for determining malignant transformation of
cells [43]. Earlier studies have indicated that activation of AP-1
and/or NF-kB is essential for the neoplastic transformation of JB6
cells [34,35,49]. Inhibition of c-Jun or AP-1 represses transforma-
tion of JB6 cells [50]. Thus, AP-1 and NF-kB transcriptional
activation instigated by metallic nickel particles may lead to cell
proliferation and neoplastic transformation. To test this hypoth-
esis, mouse epidermal JB6 P+ cells were used as an in vitro model of
skin carcinogenesis. Our results demonstrate that both metallic
nickel nano- and fine particles induced JB6 P+ cell transformation
compared to control. Interestingly, no significant difference of
colony transformation rate was found between metallic nickel
nano- and fine particle-treated cells.
Figure 6. A summative diagram of the potential pathways involved in nickel nanoparticles induced apoptosis and carcinogenesis
in JB6 cell line.
doi:10.1371/journal.pone.0092418.g006
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Taken together, the major findings of the present study include
that metallic nickel nanoparticles induced higher activation of AP-
1 and NF-kB than fine particles. We also identified that metallic
nickel nanoparticles caused a greater decrease of p53 transcription
activity and protein level than fine particles, implying that
increased growth factor receptor binding or increased hypoxic
environmental conditions may play a role in Ni nanoparticle
suppression of p53. We provided evidence that metallic nickel
nanoparticles induced a higher level of protein expressions for R-
Ras, c-myc, C-Jun, p65, and p50 in a time-dependent manner. We
demonstrated that both metallic nickel nano- and fine particles
increased anchorage-independent colony formation in JB6 P+ cells
in the soft agar assay. These results imply both metallic nickel fine
and nanoparticles are carcinogenetic in vitro, however, metallic
nickel nanoparticles may exhibit higher carcinogenic potential.
Activation of AP-1 and NF-kB, up-regulation of R-Ras and c-myc
protein expressions, as well as increase of p65 transcription activity
may all contribute to the carcinogenicity of metallic nickel
particles. Figure 6 shows a summative diagram of the possible
pathways involved in nickel nanoparticles induced apoptosis and
carcinogenesis from our previous and current study on the effects
of nickel nanoparticles on JB6 cells. It shows that in JB6 cells nickel
nanoparticles may activate the intrinsic pathway by stimulating the
death receptor Fas (CD95/Apo1) and death receptor 3 (DR3).
The Fas ligand (FasL), a homotrimeric protein acts as a ligand for
Fas and causes oligomerization of its receptor on binding, leading
to clustering of the death domains and binding of the cofactor Fas-
associated via death domain (FADD). The FADD protein binds via
its death-effector domain (DED) motif to a homologous motif in
procaspase 8, forming the death inducing signaling complex
(DISC). Upon recruitment by FADD, procaspase 8 oligomeriza-
tion drives its activation through self-cleavage. Apo3 ligand
(Apo3L) acts as a ligand for DR3 leading to binding of the
cofactor TNFR1-associated death domain (TRADD) and activates
procaspase 8. Activated Caspase 8 activates Caspase 3 through
two pathways. In the first pathway Caspase 8 causes cleavage of
procaspase 3 forming Caspase 3. Caspase 3 then activates b-actin
and lamin leading to apoptosis. In the second pathway, Caspase 8
cleaves BID (Bcl-2 interacting protein) and its COOH-terminal
part translocates to the mitochondria where it triggers the
formation of mitochondrial outer membrane pores (MOMP) by
activating Bax. The formation of MOMP releases the apoptotic
factors cytochrome-c and apoptosis inducing factor (AIF). The
release of AIF leads to chromatin condensation and DNA
fragmentation. However in this study the release of cytochrome-
c was inhibited by BCl-2. The inhibition of cytochrome-c release
by Bcl-2 suggests that nickel nanoparticles caused apoptosis by
Caspase 8/AIF cytochrome-c independent pathway. Nickel
nanoparticles may also stimulate the binding of growth factors to
the growth factor receptor leading to increased activation of Akt in
a PI3K dependent manner through R-Ras [51]. Increased Akt
activation leads to increased expression of Bcl-2 protein. Akt could
also activate phosphorylation of the pro-apoptotic protein BAD,
leading to cell survival, or inactivating it’s prosphorylation leading
to apoptosis. Akt also causes cell survival by increasing the
activation of NF-kB and AP-1. The transcription factor AP-1 is
activated via the JNK pathway and the subsequent activation of
the c-Fos and c-Jun proteins which combine to form the AP-1
dimer. The decreased p53 expression may also be caused by the
increased expression of Akt which binds and phosphorylates the
MDM2 protein which ubiquitinates p53. In addition to receptor-
mediated apoptosis, intrinsic apoptotic pathway can be activated
by various forms of cellular stress such as hypoxia. Nickel
nanoparticles may have caused hypoxic environment in the cell
leading to increased expression of HIF-1a, causing increased
activation of the c-myc protein [47]. C-myc is further increased in
expression due to the lack of feedback inhibition by p53. Our
study also shows a need for further investigation of the pathways
where p53 is involved and the events associated in its decreased
expression. A decreased apoptotic stimuli and increased stimulus
for cell proliferation, could eventually lead to tumorigenic
progression of JB6 cells treated with nickel nanoparticles. The
results obtained from this study will also be of benefit for
elucidating the pathogenic and carcinogenic potential of metallic
nickel particles. In addition, the results may be useful as a
reference when comparing the carcinogenic potential of different
nickel compounds.
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